We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Characteristics and mechanisms of latency-reversing agents in the activation of the human immunodeficiency virus 1 reservoir

    The "Shock and Kill" method is being considered as a potential treatment for eradicating HIV-1 and achieving a functional cure for acquired...

    Zhujiao Zhou, Yashuang Jiang, ... Geng Yang in Archives of Virology
    Article 29 November 2023
  2. Epstein-Barr virus variation in people living with human immunodeficiency virus in southeastern China

    Background

    Patients infected with HIV are at high risk of develo** Epstein-Barr Virus (EBV)-related diseases. The genotype and viral biological...

    Zhikai Wan, Ying Chen, ... Biao Zhu in Virology Journal
    Article Open access 31 May 2023
  3. Epstein–Barr virus-acquired immunodeficiency in myalgic encephalomyelitis—Is it present in long COVID?

    Both myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS) and long COVID (LC) are characterized by similar immunological alterations,...

    Manuel Ruiz-Pablos, Bruno Paiva, Aintzane Zabaleta in Journal of Translational Medicine
    Article Open access 17 September 2023
  4. Delivering genes with human immunodeficiency virus-derived vehicles: still state-of-the-art after 25 years

    Viruses are naturally endowed with the capacity to transfer genetic material between cells. Following early skepticism, engineered viruses have been...

    Jonas Holst Wolff, Jacob Giehm Mikkelsen in Journal of Biomedical Science
    Article Open access 09 October 2022
  5. Immunodeficiency Diseases

    Immunodeficiency disorders are conditions where the defence mechanism of the body is impaired. They show enhanced susceptibility to infection with...
    Subhash Chandra Parija in Textbook of Microbiology and Immunology
    Chapter 2023
  6. Prevalence of genital high-risk human papillomavirus infections and associated factors among women living with human immunodeficiency virus in Uganda

    Background

    Women living with HIV are at risk for cervical dysplasia and cancer worldwide. In 2015, the World Health Organization (WHO) recommended...

    Harriet Nakigozi, Rawlance Ndejjo, ... Susan Nabadda in BMC Cancer
    Article Open access 21 February 2024
  7. Human Immunodeficiency Virus as a Risk Factor for Cardiovascular Disease

    The developments in HIV treatments have increased the life expectancy of people living with HIV (PLWH), a situation that makes cardiovascular disease...

    Agnieszka Lembas, Andrzej Załęski, ... Alicja Wiercińska-Drapało in Cardiovascular Toxicology
    Article Open access 20 November 2023
  8. Predictors of hippocampal tauopathy in people with and at risk for human immunodeficiency virus infection

    Combination antiretroviral therapy (cART) has extended lifespans of people living with HIV (PWH), increasing both the risk for age-related...

    Sophie Nader, Esma Karlovich, ... Susan Morgello in Journal of NeuroVirology
    Article 05 November 2023
  9. Molecular identification and genetic characteristics of Cryptosporidium spp., Giardia duodenalis, and Enterocytozoon bieneusi in human immunodeficiency virus/acquired immunodeficiency syndrome patients in Shanghai, China

    Background

    Opportunistic infections are a ubiquitous complication in human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS)...

    Yanyan Jiang, Li Liu, ... Yujuan Shen in Parasites & Vectors
    Article Open access 04 February 2023
  10. The envelope proteins from SARS-CoV-2 and SARS-CoV potently reduce the infectivity of human immunodeficiency virus type 1 (HIV-1)

    Background

    Viroporins are virally encoded ion channels involved in virus assembly and release. Human immunodeficiency virus type 1 (HIV-1) and...

    Wyatt Henke, Hope Waisner, ... Edward Stephens in Retrovirology
    Article Open access 19 November 2022
  11. Overcoming Stigma: The Human Side of Monkeypox Virus

    Monkeypox (Mpox)Monkeypox virus is a zoonotic disease that was recently declared a public healthPublic health emergency of international concern...
    Tungki Pratama Umar, Nityanand Jain, ... Aigars Reinis in Poxviruses
    Chapter Open access 2024
  12. Novel Mutation in the Moesin (MSN) Gene Leads to Immunodeficiency with Epstein–Barr Virus (EBV) Infection and Dermatomyositis-Like Symptoms

    Purpose

    Moesin (MSN) deficiency is a recently reported combined immunodeficiency, and few cases have been reported to date. We describe a Chinese...

    Bijun Sun, Luyao Liu, ... **qiao Sun in Journal of Clinical Immunology
    Article 26 June 2024
  13. Highly mutated monoclonal antibody 3F2 targets a conformational and strain-restricted epitope in human immunodeficiency virus gp41 with significant antibody-dependent cell cytotoxicity

    Identifying epitope targets by studying the native antibody (Ab) response can identify potential novel vaccine constructs. Studies suggest that...

    Devin DeCotes, Sarah Baron, ... Mark D. Hicar in Archives of Virology
    Article 24 July 2022
  14. Biodistribution and immunity of adenovirus 5/35 and modified vaccinia Ankara vector vaccines against human immunodeficiency virus 1 clade C

    Previously, we developed a chimeric adenovirus type 5 with type 35 fiber (Ad5/35), which has high tropism to dendritic cells and low hepatoxicity....

    Masaru Shimada, Haibin Wang, ... Kenji Okuda in Gene Therapy
    Article 06 January 2022
  15. Biallelic human SHARPIN loss of function induces autoinflammation and immunodeficiency

    The linear ubiquitin assembly complex (LUBAC) consists of HOIP, HOIL-1 and SHARPIN and is essential for proper immune responses. Individuals with...

    Hirotsugu Oda, Kalpana Manthiram, ... Daniel L. Kastner in Nature Immunology
    Article 12 April 2024
  16. Anti-human immunodeficiency virus-1 activity of MoMo30 protein isolated from the traditional African medicinal plant Momordica balsamina

    Background

    Plants are used in traditional healing practices of many cultures worldwide. Momordica balsamina is a plant commonly used by traditional...

    Mahfuz Khan, Amad Diop, ... Michael D. Powell in Virology Journal
    Article Open access 22 March 2023
  17. Association of TREX1 polymorphism with disease progression in human immunodeficiency virus type-1 (HIV-1) infected patients

    The time interval between HIV-1 infection and AIDS development is not the same in all patients and depends largely on the genetic background of the...

    Nastaran Tohidi, Seyed Ali Dehghan Manshadi, Mahboubeh Hajiabdolbaghi in Virus Genes
    Article 20 September 2023
  18. Arginyl-tRNA-protein transferase 1 contributes to governing optimal stability of the human immunodeficiency virus type 1 core

    Background

    The genome of human immunodeficiency virus type 1 (HIV-1) is encapsulated in a core consisting of viral capsid proteins (CA). After viral...

    Naoki Kishimoto, Ryosuke Okano, ... Shogo Misumi in Retrovirology
    Article Open access 26 September 2021
  19. Comparison of the AmpFire® Multiplex HPV Assay to the Xpert® HPV Assay for detection of human papillomavirus and cervical disease in women with human immunodeficiency virus: a pragmatic performance evaluation

    Background

    Low- and middle-income countries (LMICs) account for nearly 85% of the global cervical cancer burden, yet have the least access to...

    Sikhulile Moyo, Doreen Ramogola-Masire, ... Rebecca Luckett in Infectious Agents and Cancer
    Article Open access 10 May 2023
Did you find what you were looking for? Share feedback.